Glucosio Con Potassio Cloruro Monico (Potassium Chloride, Glucose Monohydrate)

Glucosio Con Potassio Cloruro Monico is used in clinical settings where potassium replacement and fluid resuscitation are required.

• Correction of hypokalemia (low blood potassium) in patients receiving diuretics, laxatives, or gastrointestinal losses.
• Support of electrolyte balance during postoperative recovery or intensive care management.
• Provision of an energy source and osmotic agent during intravenous fluid therapy.
• Adjunct to blood transfusion or chemotherapy protocols to maintain plasma potassium levels.
• Use in pediatric or neonatal care when precise potassium dosing is needed under medical supervision.

Potential adverse reactions to the intravenous solution are categorized by frequency and severity.

Common

• Mild irritation at the infusion site, such as erythema or discomfort.
• Transient nausea or vomiting related to rapid infusion.
• Mild hyperglycemia in patients with impaired glucose tolerance.
• Temporary increase in serum potassium that resolves with monitoring.

Serious

• Severe hyperkalemia leading to cardiac arrhythmias.
• Anaphylactic or severe allergic reaction, including bronchospasm or hypotension.
• Local tissue necrosis if extravasation occurs.

Clinicians should observe specific precautions when prescribing Glucosio Con Potassio Cloruro Monico to minimize risks and ensure therapeutic effectiveness.

• Assess serum potassium and glucose levels before initiating therapy.
• Adjust infusion rate in patients with renal impairment or heart failure.
• Avoid rapid administration to reduce the risk of hyperkalemia.
• Monitor cardiac rhythm continuously during high‑dose potassium infusion.
• Use a compatible IV set and avoid mixing with calcium‑containing solutions.
• Confirm correct patient identity and dosage calculations, especially in pediatric cases.
• Document any adverse reactions promptly in the medical record.

The potassium‑chloride/glucose solution may interact with other medications, influencing electrolyte balance or infusion compatibility.

Avoid

• Concurrent administration of other potassium salts or potassium‑sparing diuretics without monitoring.
• Co‑infusion with calcium gluconate or calcium chloride, which can precipitate insoluble salts.
• Mixing with alkaline solutions that may cause precipitation of potassium chloride.

Use with caution

• Concurrent use of insulin or glucose‑lowering agents, which may exacerbate hypoglycemia.
• Renal replacement therapies such as dialysis, requiring dose adjustments.
• Beta‑adrenergic agonists that shift potassium intracellularly, potentially masking serum levels.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may affect renal potassium handling.